欢迎来到360期刊网!
学术期刊
  • 学术期刊
  • 文献
  • 百科
电话

您当前的位置:   首页  >  SCI文献  >  Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data.

Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data.
影响因子:71.421 DOI:10.1016/S1473-3099(19)30695-4
作者: Barr DA,Lewis JM,Feasey N,Schutz C,Kerkhoff AD,Jacob ST,Andrews B,Kelly P,Lakhi S,Muchemwa L,Bacha HA,Hadad DJ,Bedell R,van Lettow M,Zachariah R,Crump JA,Alland D,Corbett EL,Gopinath K,Singh S,Griesel R,Maartens G,Mendelson M,Ward AM,Parry CM,Talbot EA,Munseri P,Dorman SE,Martinson N,Shah M,Cain K,Heilig CM,Varma JK,von Gottberg A,Sacks L,Wilson D,Squire SB,Lalloo DG,Davies G,Meintjes G 发表时间:2020-08-29 11:14:55
keywords: Barr DALewis JMFeasey NSchutz CKerkhoff ADJacob STAndrews BKelly PLakhi SMuchemwa LBacha HAHadad DJBedell Rvan Lettow MZachariah RCrump JAAlland DCorbett ELGopinath KSingh SGriesel RMaartens GMendelson MWard AMParry CMTalbot EAMunseri PDorman SEMartinson NShah MCain KHeilig CMVarma JKvon Gottberg ASacks LWilson DSquire SBLalloo DGDavies GMeintjes G
关键词:
Abstract
BACKGROUND:The clinical and epidemiological significance of HIV-associated Mycobacterium tuberculosis bloodstream infection (BSI) is incompletely understood. We hypothesised that M tuberculosis BSI prevalence has been underestimated, that it independently predicts death, and that sputum Xpert MTB/RIF has suboptimal diagnostic yield for M tuberculosis BSI. METHODS:We did a systematic review and individual patient data (IPD) meta-analysis of studies performing routine mycobacterial blood culture in a prospectively defined patient population of people with HIV aged 13 years or older. Studies were identified through searching PubMed and Scopus up to Nov 10, 2018, without language or date restrictions and through manual review of reference lists. Risk of bias in the included studies was assessed with an adapted QUADAS-2 framework. IPD were requested for all identified studies and subject to harmonised inclusion criteria: age 13 years or older, HIV positivity, available CD4 cell count, a valid mycobacterial blood culture result (excluding patients with missing data from lost or contaminated blood cultures), and meeting WHO definitions for suspected tuberculosis (presence of screening symptom). Predicted probabilities of M tuberculosis BSI from mixed-effects modelling were used to estimate prevalence. Estimates of diagnostic yield of sputum testing with Xpert (or culture if Xpert was unavailable) and of urine lipoarabinomannan (LAM) testing for M tuberculosis BSI were obtained by two-level random-effect meta-analysis. Estimates of mortality associated with M tuberculosis BSI were obtained by mixed-effect Cox proportional-hazard modelling and of effect of treatment delay on mortality by propensity-score analysis. This study is registered with PROSPERO, number 42016050022. FINDINGS:We identified 23 datasets for inclusion (20 published and three unpublished at time of search) and obtained IPD from 20, representing 96·2% of eligible IPD. Risk of bias for the included studies was assessed to be generally low except for on the patient selection domain, which was moderate in most studies. 5751 patients met harmonised IPD-level inclusion criteria. Technical factors such as number of blood cultures done, timing of blood cultures relative to blood sampling, and patient factors such as inpatient setting and CD4 cell count, explained significant heterogeneity between primary studies. The predicted probability of M tuberculosis BSI in hospital inpatients with HIV-associated tuberculosis, WHO danger signs, and a CD4 count of 76 cells per μL (the median for the cohort) was 45% (95% CI 38-52). The diagnostic yield of sputum in patients with M tuberculosis BSI was 77% (95% CI 63-87), increasing to 89% (80-94) when combined with urine LAM testing. Presence of M tuberculosis BSI compared with its absence in patients with HIV-associated tuberculosis increased risk of death before 30 days (adjusted hazard ratio 2·48, 95% CI 2·05-3·08) but not after 30 days (1·25, 0·84-2·49). In a propensity-score matched cohort of participants with HIV-associated tuberculosis (n=630), mortality increased in patients with M tuberculosis BSI who had a delay in anti-tuberculosis treatment of longer than 4 days compared with those who had no delay (odds ratio 3·15, 95% CI 1·16-8·84). INTERPRETATION:In critically ill adults with HIV-tuberculosis, M tuberculosis BSI is a frequent manifestation of tuberculosis and predicts mortality within 30 days. Improved diagnostic yield in patients with M tuberculosis BSI could be achieved through combined use of sputum Xpert and urine LAM. Anti-tuberculosis treatment delay might increase the risk of mortality in these patients. FUNDING:This study was supported by Wellcome fellowships 109105Z/15/A and 105165/Z/14/A.
摘 要
期刊介绍
《LANCET INFECTIOUS DISEASES》 (点击进入期刊详情)
英文简介 : Published by The Lancet. ISSN: 1473-3099. A lively monthly journal of review, opinion, and news covering international issues relevant to infectious disease specialists worldwide.
中文简介 : (来自Google、百度翻译) 发表在《柳叶刀》杂志上。ISSN: 1473 - 3099。 一个活泼的月刊的评论,意见,和新闻报道的国际问题有关的传染病专家世界各地。
CIRCULATION RESEARCH 期刊中科院评价数据
新中科院分区
大类(学科) 小类(学科) 学科排名
医学

INFECTIOUS DISEASES (传染病学)

1/88
新发布的期刊年发文量
年度总发文量 年度论文发表量 年度综述发表量
123 102 21

总被引频次 :23088

特征因子 : 0.073350

影响因子趋势图

相关文献

360期刊网

专注医学期刊服务15年

  • 您好:请问您咨询什么等级的期刊?专注医学类期刊发表15年口碑企业,为您提供以下服务:

  • 1.医学核心期刊发表-全流程服务
    2.医学SCI期刊-全流程服务
    3.论文投稿服务-快速报价
    4.期刊推荐直至录用,不成功不收费

  • 客服正在输入...

x
立即咨询